Washington § 69.04.500 Drugs—Misbranding by failure to give directions for use and warnings.

Washington Statutes

§ 69.04.500 — Drugs—Misbranding by failure to give directions for use and warnings.

Washington § 69.04.500

Title 69FOOD, DRUGS, COSMETICS, AND POISONS

Ch. 69.04INTRASTATE COMMERCE IN DRUGS AND COSMETICS

This text of Washington § 69.04.500 (Drugs—Misbranding by failure to give directions for use and warnings.) is published on Counsel Stack Legal Research, covering Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Wash. Rev. Code § 69.04.500 (2026).

Text

A drug or device shall be deemed to be misbranded unless its labeling bears (1) adequate directions for use; and (2) such adequate warnings against use in those pathological conditions or by children where its use may be dangerous to health, or against unsafe dosage or methods or duration of administration or application, in such manner and form, as are necessary for the protection of users: PROVIDED, That where any requirement of clause (1) of this section as applied to any drug or device, is not necessary for the protection of the public health, the director shall promulgate regulations exempting such drug or device from such requirements. Such regulations shall include the exemptions prescribed under section 502(f)(1) of the federal act, insofar as such exemptions are applicable hereund

Free access — add to your briefcase to read the full text and ask questions with AI

A drug or device shall be deemed to be misbranded unless its labeling bears (1) adequate directions for use; and (2) such adequate warnings against use in those pathological conditions or by children where its use may be dangerous to health, or against unsafe dosage or methods or duration of administration or application, in such manner and form, as are necessary for the protection of users: PROVIDED, That where any requirement of clause (1) of this section as applied to any drug or device, is not necessary for the protection of the public health, the director shall promulgate regulations exempting such drug or device from such requirements. Such regulations shall include the exemptions prescribed under section 502(f)(1) of the federal act, insofar as such exemptions are applicable hereunder.